Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |